Cargando…

Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related Differences

3,4-Methylenedioxymethamphetamine (MDMA, “ecstasy”) is an amphetamine-related drug that may damage the dopaminergic nigrostriatal system. To investigate the mechanisms that sustain this toxic effect and ascertain their sex-dependence, we evaluated in the nigrostriatal system of MDMA-treated (4 × 20 ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costa, Giulia, Caputi, Francesca Felicia, Serra, Marcello, Simola, Nicola, Rullo, Laura, Stamatakos, Serena, Sanna, Fabrizio, Germain, Marc, Martinoli, Maria-Grazia, Candeletti, Sanzio, Morelli, Micaela, Romualdi, Patrizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430399/ https://www.ncbi.nlm.nih.gov/pubmed/34512343 http://dx.doi.org/10.3389/fphar.2021.713486

Ejemplares similares

Interplay between the Endogenous Opioid System and Proteasome Complex: Beyond Signaling
por: Caputi, Francesca Felicia, et al.
Publicado: (2019)

Modulation of the Negative Affective Dimension of Pain: Focus on Selected Neuropeptidergic System Contributions
por: Caputi, Francesca Felicia, et al.
Publicado: (2019)

Chronic Trazodone and Citalopram Treatments Increase Trophic Factor and Circadian Rhythm Gene Expression in Rat Brain Regions Relevant for Antidepressant Efficacy
por: Carboni, Lucia, et al.
Publicado: (2022)

Dysregulation of Nociceptin/Orphanin FQ and Dynorphin Systems in the Extended Amygdala of Alcohol Preferring Marchigian Sardinian (msP) Rats
por: Caputi, Francesca Felicia, et al.
Publicado: (2021)

An Exploratory Pilot Study of Changes in Global DNA Methylation in Patients Undergoing Major Breast Surgery Under Opioid-Based General Anesthesia
por: Caputi, Francesca Felicia, et al.
Publicado: (2021)

Interplay between Prokineticins and Histone Demethylase KDM6A in a Murine Model of Bortezomib-Induced Neuropathy
por: Rullo, Laura, et al.
Publicado: (2021)

Effects of Different Opioid Drugs on Oxidative Status and Proteasome Activity in SH-SY5Y Cells
por: Rullo, Laura, et al.
Publicado: (2022)

The standardized Withania somnifera Dunal root extract alters basal and morphine-induced opioid receptor gene expression changes in neuroblastoma cells
por: Caputi, Francesca Felicia, et al.
Publicado: (2018)

Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine (“Ecstasy”) induced cytoskeletal damage
por: Bavato, F., et al.
Publicado: (2022)

Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists
por: Coluzzi, Flaminia, et al.
Publicado: (2020)

Targeting the JAK/STAT Pathway: A Combined Ligand- and Target-Based Approach
por: Galvez-Llompart, Maria, et al.
Publicado: (2021)

Early-life nicotine or cotinine exposure produces long-lasting sleep alterations and downregulation of hippocampal corticosteroid receptors in adult mice
por: Bastianini, Stefano, et al.
Publicado: (2021)

Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation
por: Coluzzi, Flaminia, et al.
Publicado: (2022)

3,4-methylenedioxymethamphetamine (MDMA): current perspectives
por: Meyer, Jerrold S
Publicado: (2013)

Naringin: A Protector of the Nigrostriatal Dopaminergic Projection
por: Jung, Un Ju, et al.
Publicado: (2014)

3,4-Methylenedioxymethamphetamine facilitates fear extinction learning
por: Young, M B, et al.
Publicado: (2015)

Effects of 3,4-Methylenedioxymethamphetamine Administration on Retinal Physiology in the Rat
por: Martins, João, et al.
Publicado: (2011)

Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms
por: McCann, Una D., et al.
Publicado: (2007)

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
por: Sessa, Ben, et al.
Publicado: (2019)

The Effects of 3,4-methylenedioxymethamphetamine on Neurogenesis in the Hippocampus of Male Rats
por: Soleimani Asl, Sara, et al.
Publicado: (2020)

Nigrostriatal dopaminergic depletion increases static orofacial allodynia
por: Dieb, Wisam, et al.
Publicado: (2016)

Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic Neurotransmission
por: Qin, Qi, et al.
Publicado: (2016)

Neuronal reorganization in adult rats neonatally exposed to (±)-3,4-methylenedioxymethamphetamine
por: Williams, Michael T., et al.
Publicado: (2014)

A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)
por: Capela, João Paulo, et al.
Publicado: (2022)

Dynorphinergic system alterations in the corticostriatal circuitry of neuropathic mice support its role in the negative affective component of pain
por: Palmisano, M., et al.
Publicado: (2018)

Zingiber Officinale Alters 3,4-methylenedioxymethamphetamine-Induced Neurotoxicity in Rat Brain
por: Mehdizadeh, Mehdi, et al.
Publicado: (2012)

Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
por: Wunderli, Michael D, et al.
Publicado: (2017)

The effect of 3,4- methylenedioxymethamphetamine on expression of neurotrophic factors in hippocampus of male rats
por: Soleimani Asl, Sara, et al.
Publicado: (2017)

Why Psychiatry Needs 3,4-Methylenedioxymethamphetamine: A Child Psychiatrist’s Perspective
por: Sessa, Ben
Publicado: (2017)

Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy
por: Oeri, Hans Emanuel
Publicado: (2020)

3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review
por: Inouye, Ann, et al.
Publicado: (2022)

Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review
por: Fonseka, Lakshan N, et al.
Publicado: (2023)

A Current Review of Cypermethrin-Induced Neurotoxicity and Nigrostriatal Dopaminergic Neurodegeneration
por: Singh, Anand Kumar, et al.
Publicado: (2012)

Dopa-responsive dystonia: a syndrome of selective nigrostriatal dopaminergic deficiency.
por: Jeon, B. S.
Publicado: (1997)

Lesion of the dopaminergic nigrostriatal pathway induces trigeminal dynamic mechanical allodynia
por: Dieb, Wisam, et al.
Publicado: (2014)

Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism
por: Lee, Seung Ha, et al.
Publicado: (2017)

Atrazine Causes Autophagy- and Apoptosis-Related Neurodegenerative Effects in Dopaminergic Neurons in the Rat Nigrostriatal Dopaminergic System
por: Song, Xiao-Yao, et al.
Publicado: (2015)

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings
por: Baumann, Michael H., et al.
Publicado: (2006)

The influence of the host microbiome on 3,4-methylenedioxymethamphetamine (MDMA)-induced hyperthermia and vice versa
por: Ridge, Emily A., et al.
Publicado: (2019)

In vivo Assessment of the Human Nigrostriatal Dopaminergic System Using Positron Emission Tomography
por: Leenders, K. L.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_i25vpc9tiijh8enl3hvbv5cuj7